Study of the effects of Prolonged-Release Torasemide on myocardial fibrosis in hypertensive patients with chronic heart failure: design and baseline characteristics

被引：0
|
作者：
Gonzalez Juanatey, J. R. [1 ]
Anguita, M. [2 ]
Coca, A. [3 ]
De Teresa, E. [4 ]
Diez, J. [5 ]
Fernandez, E. [6 ]
Castro Beiras, A. [7 ]
机构：
[1] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela, Spain
[2] Hosp Univ Reina Sofia, Cordoba, Spain
[3] Hosp Clin Univ Barcelona, Barcelona, Spain
[4] Hosp Virgen Victoria, Malaga, Spain
[5] Ctr Invest Med Aplicada, Pamplona, Spain
[6] Novag Ferrer Int, Barcelona, Spain
[7] Univ A Coruna, La Coruna, Spain
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：720 / 720
页数：1
相关论文
共 50 条
  • [41] The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics
    Lowrie, Richard
    Mair, Frances S.
    Greenlaw, Nicola
    Forsyth, Paul
    McConnachie, Alex
    Richardson, Janice
    Khan, Nina
    Morrison, Deborah
    Messow, Claudia-Martina
    Rae, Brian
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (08) : 917 - 924
  • [42] PROTECTIVE EFFECTS OF PAEONIFLORIN AGAINST MYOCARDIAL FIBROSIS IN ISOPRENALINE-INDUCED CHRONIC HEART FAILURE RATS
    Chen, J.
    Liu, M.
    Li, L. L.
    Ke, J. T.
    Zhou, W. Y.
    Huang, D.
    Wu, W.
    HEART, 2015, 101 : A9 - A9
  • [43] Study on the mechanism underlying Trichosanthis peel injection-induced improvements in myocardial fibrosis markers in patients with chronic heart failure
    He, Yue
    Gu, Xinsheng
    Yang, Zhou
    Wang, Hao
    Liu, Ping
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2024, 51 (04)
  • [44] Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure (vol 67, pg 384, 2003)
    Yamato, M
    Sasaki, T
    Honda, K
    Fukuda, M
    Akutagawa, O
    Okamoto, M
    Hayashi, T
    CIRCULATION JOURNAL, 2003, 67 (07) : 649 - 649
  • [45] Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study)
    Ghio, Stefano
    Freemantle, Nick
    Serio, Alessandra
    Magrini, Giulia
    Scelsi, Laura
    Pasotti, Michele
    Cleland, John G. F.
    Tavazzi, Luigi
    EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2006, 7 (05): : 373 - 378
  • [46] Metabolic Effects of Metformin in Chronic Heart Failure Patients are Mediated by Gut Incretin Release
    Melenovsky, Vojtech
    Stolarikova, Eva
    Belinova, Lenka
    Velebova, Katerina
    Szegetova, Marketa
    Kuda, Ondrej
    Kopecky, Jan
    Pelikanova, Terezie
    CIRCULATION, 2017, 136
  • [47] Effect of furosemide and torasemide on heart rate variability and ventricular rhythm disorders in patients with chronic heart failure complicating ischemic heart disease: comparative nonrandomized study
    Shugushev, H. H.
    Gaeva, A. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2010, 6 (04) : 513 - 517
  • [48] Modulation of BNP release in relation to myocardial scarring, ischemia and hibernation on PET in patients with chronic heart failure
    Allen, DS
    Aktas, MK
    Jaber, WA
    Chuang, HH
    Tang, WHW
    Taylor, DO
    Starling, RC
    Yamani, MH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 38A - 38A
  • [49] Rationale, design and baseline characteristics of the MyoVasc study: A prospective cohort study investigating development and progression of heart failure
    Goebel, Sebastian
    Prochaska, Juergen H.
    Troebs, Sven-Oliver
    Panova-Noeva, Marina
    Espinola-Klein, Christine
    Michal, Matthias
    Lackner, Karl J.
    Gori, Tommaso
    Muenzel, Thomas
    Wild, Philipp S.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (09) : 1009 - 1018
  • [50] Osteopontin and interleukin-15 serum levels relation to myocardial function in hypertensive patients with chronic heart failure
    Honchar, O. V.
    Kozhemiaka, A. V.
    Kovalyova, O. M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 332 - 332
12345